1. Market Research
  2. > Pathology Industry

Pancreatic Cancer Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Antigen, Therapeutics, Cancer Diagnostic, Diagnostics, Therapy.


 
1-10 of 62 reports for Pancreatic Cancer

Purchase Reports From Reputable Market Research Publishers

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

Global Pancreatic Cancer Partnering 2010 to 2016

Global Pancreatic Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Pancreatic Cancer - Pipeline Review, H2 2015

Pancreatic Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H2 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. ...

Metastatic Pancreatic Cancer - Pipeline Review, H2 2015

Metastatic Pancreatic Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • December 2015
  • by Global Markets Direct

Metastatic Pancreatic Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Pancreatic ...

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape

  • $ 4 995
  • Industry report
  • December 2015
  • by GBI Research

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape Summary Pancreatic Cancer (PC) is a disease predominately ...

Pancreatic Cancer - Pipeline Review, 2015

Pancreatic Cancer - Pipeline Review, 2015

  • $ 4 000
  • Industry report
  • October 2015
  • by Global Data

Pancreatic Cancer - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer - Pipeline Review, 2015" provides an overview of Pancreatic Cancer diagnostic tests currently ...

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for pancreatic cancer drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ...

The 2016-2021 Outlook for Pancreatic Cancer Drugs in India

The 2016-2021 Outlook for Pancreatic Cancer Drugs in India

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for pancreatic cancer drugs across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry ...

The 2016-2021 Outlook for Pancreatic Cancer Drugs in Greater China

The 2016-2021 Outlook for Pancreatic Cancer Drugs in Greater China

  • $ 595
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for pancreatic cancer drugs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, ...

About 1 500 reports for Pancreatic Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2015
    11 pages
  • Pancreatic Canc...  

    Cancer  

  • United States  

    Africa  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.